Most human papillomavirus (HPV) infections are transient. 1 Among other things, unnecessary overtreatment can cause unnecessary future pregnancy complications, but an approach to persistent HPV infection that is too cavalier may result in unacceptably high rates of cervical carcinoma. 2 Cytologists recognize some of the morphologic changes in Papanicolaou (Pap) tests with an excellent specificity, but a single test is associated with a low sensitivity (70%). Screening specificity is greatly improved by the addition of HPV testing for triage of mildly abnormal Pap smears (atypical squamous cells), and sensitivity is increased through co-testing for primary screening. Improved sensitivity, though, is almost always hampered by decreased specificity. It is really hard to drive both sensitivity and specificity. Being able to improve either or both cervical management strategies would have an impact on narrowing and improving the referral population of patients for colposcopic examination. This improvement may be here in the form of dual immunohistochemical staining for p16 and Ki67 in cervical cytology samples, as discussed in the article by Schmidt et al. in the current issue of Cancer Cytopathology. 1 To appreciate their article, a few pathways need to be understood at a basic level. CINtecþ is the product name by the German-based company mtm (mtm laboratories AG, Heidelberg, Germany) of the dual-stain immunohistochemical kit for p16 and Ki67. It is a relatively simple biomarker that capitalizes on the disruption of the retinoblastoma protein pathway. E2F is a transcription factor that helps commit a cell to divide but is inactive when bound to retinoblastoma protein (Rb). When the E7 portion of high-risk HPVs binds to the host epithelial cell Rb, then E2F is released. This results in committing a cell to divide (Therefore, in tissue samples, we see an increase in suprabasal dividing cells, which can be detected by the use of cell cycle antibodies such as Ki67.) and simultaneously the negative regulator p16 attempts to slow down and balance cell cycling because it, too, is activated by free E2F. In uninfected squamous epithelium, p16 is normally only rarely detectable by immunohistochemistry in the basal cells. In contrast, there is a paradoxical increase in p16 in high-grade dysplasia, which can also be detected with immunohistochemistry.